O	O	0	8	Possible	Possible	B-NP	JJ	O	2	NMOD	O
O	O	9	13	role	role	I-NP	NN	O	0	ROOT	O
O	O	14	16	of	of	B-PP	IN	O	2	NMOD	O
T13	B-Entity	17	24	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD	B-protein
T13	I-Entity	25	31	factor	factor	I-NP	NN	I-protein	9	NMOD	I-protein
T13	I-Entity	31	32	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T13	I-Entity	32	37	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T13	I-Entity	38	39	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	40	48	activity	activity	I-NP	NN	O	3	PMOD	O
O	O	49	51	in	in	B-PP	IN	O	2	NMOD	O
T14	B-Entity	52	60	germline	germline	B-NP	NN	B-DNA	14	NMOD	B-DNA
T14	I-Entity	61	62	C	C	I-NP	NN	O	14	NMOD	O
T14	I-Entity	63	70	epsilon	epsilon	I-NP	NN	O	14	NMOD	O
O	O	71	84	transcription	transcription	I-NP	NN	O	10	PMOD	O
O	O	85	87	in	in	B-PP	IN	O	14	NMOD	O
O	O	88	89	a	a	B-NP	DT	O	22	NMOD	O
O	O	90	95	human	human	I-NP	JJ	B-cell_line	22	NMOD	B-cell_line
O	O	96	103	Burkitt	Burkitt	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	104	112	lymphoma	lymphoma	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	113	114	B	B	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	115	119	cell	cell	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	120	124	line	line	I-NP	NN	I-cell_line	15	PMOD	I-cell_line
O	O	124	125	.	.	O	.	O	2	P	O

T15	B-Entity	127	134	Nuclear	Nuclear	B-NP	JJ	B-protein	2	NMOD	B-protein
T15	I-Entity	135	141	factor	factor	I-NP	NN	I-protein	12	SUB	I-protein
T15	I-Entity	141	142	-	-	B-VP	HYPH	O	2	NMOD	O
T15	I-Entity	142	147	kappa	kappa	B-NP	NN	O	5	NMOD	O
T15	I-Entity	148	149	B	B	I-NP	NN	O	3	OBJ	O
O	O	150	151	(	(	O	(	O	11	DEP	O
T16	B-Entity	151	153	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T16	I-Entity	153	154	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T16	I-Entity	154	159	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T16	I-Entity	160	161	B	B	I-NP	NN	I-protein	11	DEP	I-protein
O	O	161	162	)	)	O	)	O	5	NMOD	O
O	O	163	168	plays	play	B-VP	VBZ	O	22	VMOD	O
O	O	169	170	a	a	B-NP	DT	O	15	NMOD	O
O	O	171	176	broad	broad	I-NP	JJ	O	15	NMOD	O
O	O	177	181	role	role	I-NP	NN	O	12	OBJ	O
O	O	182	184	in	in	B-PP	IN	O	12	VMOD	O
O	O	185	189	gene	gene	B-NP	NN	O	18	NMOD	O
O	O	190	200	regulation	regulation	I-NP	NN	O	16	PMOD	O
O	O	200	201	,	,	O	,	O	22	P	O
O	O	202	205	but	but	O	CC	O	22	VMOD	O
O	O	206	208	it	it	B-NP	PRP	O	22	SUB	O
O	O	209	211	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	212	215	not	not	O	RB	O	22	VMOD	O
O	O	216	223	evident	evident	B-ADJP	JJ	O	22	PRD	O
O	O	224	231	whether	whether	B-SBAR	IN	O	22	VMOD	O
T17	B-Entity	232	234	NF	NF	B-NP	NN	B-protein	29	NMOD	B-protein
T17	I-Entity	234	235	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T17	I-Entity	235	240	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T17	I-Entity	241	242	B	B	I-NP	NN	I-protein	30	SUB	I-protein
O	O	243	247	acts	act	B-VP	VBZ	O	25	SBAR	O
O	O	248	250	as	as	B-PP	IN	O	30	VMOD	O
O	O	251	252	a	a	B-NP	DT	O	34	NMOD	O
O	O	253	262	messenger	messenger	I-NP	NN	O	34	NMOD	O
O	O	263	269	system	system	I-NP	NN	O	31	PMOD	O
O	O	270	273	for	for	B-PP	IN	O	34	NMOD	O
T18	B-Entity	274	282	germline	germline	B-NP	NN	B-DNA	39	NMOD	B-DNA
T18	I-Entity	283	284	C	C	I-NP	NN	O	39	NMOD	O
T18	I-Entity	285	292	epsilon	epsilon	I-NP	NN	O	39	NMOD	O
O	O	293	306	transcription	transcription	I-NP	NN	O	35	PMOD	O
O	O	306	307	.	.	O	.	O	22	P	O

O	O	308	310	We	We	B-NP	PRP	O	2	SUB	O
O	O	311	317	report	report	B-VP	VBP	O	0	ROOT	O
O	O	318	322	here	here	B-ADVP	RB	O	2	VMOD	O
O	O	323	327	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	328	331	the	the	B-NP	DT	O	7	NMOD	O
O	O	332	341	signaling	signaling	I-NP	NN	O	7	NMOD	O
O	O	342	349	cascade	cascade	I-NP	NN	O	27	SUB	O
O	O	350	359	triggered	trigger	B-VP	VBN	O	7	NMOD	O
O	O	360	362	by	by	B-PP	IN	O	8	VMOD	O
T1	B-Protein	363	374	interleukin	interleukin	B-NP	NN	B-protein	9	PMOD	B-protein
T1	I-Protein	374	375	-	-	O	HYPH	O	10	NMOD	O
T1	I-Protein	375	376	4	4	B-NP	CD	O	11	PMOD	O
O	O	377	378	(	(	O	(	O	17	DEP	O
T2	B-Protein	378	380	IL	IL	B-NP	NN	B-protein	15	NMOD	B-protein
T2	I-Protein	380	381	-	-	O	HYPH	I-protein	17	DEP	I-protein
T2	I-Protein	381	382	4	4	B-NP	CD	I-protein	15	NMOD	I-protein
O	O	382	383	)	)	O	)	O	12	NMOD	O
O	O	384	386	or	or	O	CC	O	19	NMOD	O
O	O	387	391	anti	anti	B-NP	AFX	B-protein	12	NMOD	B-protein
O	O	391	392	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T3	B-Protein	392	396	CD40	CD40	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	397	407	monoclonal	monoclonal	I-NP	JJ	I-protein	23	NMOD	I-protein
O	O	408	416	antibody	antibody	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	417	418	(	(	O	(	O	26	DEP	O
O	O	418	421	mAb	mAb	B-NP	NN	B-protein	26	DEP	B-protein
O	O	421	422	)	)	O	)	O	23	NMOD	O
O	O	423	435	participates	participate	B-VP	VBZ	O	4	SBAR	O
O	O	436	438	in	in	B-PP	IN	O	27	VMOD	O
T19	B-Entity	439	441	NF	NF	B-NP	NN	B-protein	33	NMOD	B-protein
T19	I-Entity	441	442	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T19	I-Entity	442	447	kappa	kappa	I-NP	NN	I-protein	33	NMOD	I-protein
T19	I-Entity	448	449	B	B	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	450	460	activation	activation	I-NP	NN	O	28	PMOD	O
O	O	461	472	responsible	responsible	B-ADJP	JJ	O	33	NMOD	O
O	O	473	476	for	for	B-PP	IN	O	34	AMOD	O
T20	B-Entity	477	485	germline	germline	B-NP	NN	B-DNA	39	NMOD	B-DNA
T20	I-Entity	486	487	C	C	I-NP	NN	O	39	NMOD	O
T20	I-Entity	488	495	epsilon	epsilon	I-NP	NN	O	39	NMOD	O
O	O	496	509	transcription	transcription	I-NP	NN	O	35	PMOD	O
O	O	510	512	in	in	B-PP	IN	O	39	NMOD	O
O	O	513	514	a	a	B-NP	DT	O	47	NMOD	O
O	O	515	520	human	human	I-NP	JJ	B-cell_line	47	NMOD	B-cell_line
O	O	521	528	Burkitt	Burkitt	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	529	537	lymphoma	lymphoma	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	538	539	B	B	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	540	544	cell	cell	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	545	549	line	line	I-NP	NN	I-cell_line	49	NMOD	I-cell_line
O	O	549	550	,	,	O	,	O	49	P	O
O	O	551	556	DND39	DND39	B-NP	NN	B-cell_line	40	PMOD	B-cell_line
O	O	556	557	.	.	O	.	O	2	P	O

O	O	558	562	Both	Both	O	CC	O	9	NMOD	O
T4	B-Protein	563	565	IL	IL	B-NP	NN	B-protein	3	NMOD	B-protein
T4	I-Protein	565	566	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T4	I-Protein	566	567	4	4	I-NP	CD	I-protein	3	NMOD	I-protein
O	O	568	571	and	and	O	CC	O	9	NMOD	O
O	O	572	576	anti	anti	B-NP	AFX	O	9	NMOD	O
O	O	576	577	-	-	I-NP	HYPH	B-protein	9	NMOD	B-protein
T5	B-Protein	577	581	CD40	CD40	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	582	585	mAb	mAb	I-NP	NN	I-protein	10	SUB	I-protein
O	O	586	593	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	594	604	activation	activation	B-NP	NN	O	35	NMOD	O
O	O	605	607	of	of	B-PP	IN	O	11	NMOD	O
O	O	608	628	phosphatidylinositol	phosphatidylinositol	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	629	630	3	3	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	630	631	-	-	I-NP	HYPH	I-protein	16	NMOD	I-protein
O	O	631	637	kinase	kinase	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	638	639	(	(	O	(	O	21	DEP	O
O	O	639	642	PI3	PI3	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	642	643	-	-	B-NP	HYPH	I-protein	20	P	I-protein
O	O	643	649	kinase	kinase	I-NP	NN	I-protein	21	DEP	I-protein
O	O	649	650	)	)	O	)	O	16	NMOD	O
O	O	650	651	,	,	O	,	O	35	P	O
O	O	652	665	translocation	translocation	B-NP	NN	O	35	NMOD	O
O	O	666	668	of	of	B-PP	IN	O	23	NMOD	O
O	O	669	670	a	a	B-NP	DT	O	27	NMOD	O
O	O	671	675	zeta	zeta	I-NP	NN	O	27	NMOD	O
O	O	676	683	isoform	isoform	I-NP	NN	O	24	PMOD	O
O	O	684	686	of	of	B-PP	IN	O	27	NMOD	O
O	O	687	694	protein	protein	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	695	701	kinase	kinase	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	702	703	C	C	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	703	704	,	,	O	,	O	35	P	O
O	O	705	708	and	and	O	CC	O	35	NMOD	O
O	O	709	716	nuclear	nuclear	B-NP	JJ	O	35	NMOD	O
O	O	717	727	expression	expression	I-NP	NN	O	10	OBJ	O
O	O	728	730	of	of	B-PP	IN	O	35	NMOD	O
T21	B-Entity	731	733	NF	NF	B-NP	NN	B-protein	40	NMOD	B-protein
T21	I-Entity	733	734	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T21	I-Entity	734	739	kappa	kappa	I-NP	NN	I-protein	40	NMOD	I-protein
T21	I-Entity	740	741	B	B	I-NP	NN	I-protein	36	PMOD	I-protein
O	O	741	742	.	.	O	.	O	10	P	O

O	O	743	746	All	All	B-NP	DT	O	3	NMOD	O
O	O	747	751	such	such	I-NP	JJ	O	3	NMOD	O
O	O	752	758	events	event	I-NP	NNS	O	4	SUB	O
O	O	759	763	were	be	B-VP	VBD	O	0	ROOT	O
O	O	764	773	abrogated	abrogate	I-VP	VBN	O	4	VC	O
O	O	774	776	by	by	B-PP	IN	O	5	VMOD	O
O	O	777	786	treatment	treatment	B-NP	NN	O	6	PMOD	O
O	O	787	791	with	with	B-PP	IN	O	7	NMOD	O
O	O	792	800	LY294002	LY294002	B-NP	NN	O	13	NMOD	O
O	O	800	801	,	,	O	,	O	13	P	O
O	O	802	803	a	a	B-NP	DT	O	13	NMOD	O
O	O	804	812	specific	specific	I-NP	JJ	O	13	NMOD	O
O	O	813	822	inhibitor	inhibitor	I-NP	NN	O	8	PMOD	O
O	O	823	825	of	of	B-PP	IN	O	13	NMOD	O
O	O	826	829	PI3	PI3	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	829	830	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
O	O	830	836	kinase	kinase	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	836	837	.	.	O	.	O	4	P	O

O	O	838	840	In	In	B-PP	IN	O	19	VMOD	O
O	O	841	849	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	849	850	,	,	O	,	O	19	P	O
T22	B-Entity	851	852	N	N	B-NP	NN	O	17	NMOD	O
T22	I-Entity	852	853	-	-	B-NP	HYPH	O	17	P	O
T22	I-Entity	853	859	acetyl	acetyl	I-NP	NN	O	17	NMOD	O
T22	I-Entity	859	860	-	-	B-NP	HYPH	O	17	P	O
T22	I-Entity	860	861	L	L	I-NP	NN	O	17	NMOD	O
T22	I-Entity	861	862	-	-	O	HYPH	O	17	P	O
T22	I-Entity	862	870	cysteine	cysteine	B-NP	NN	O	17	NMOD	O
O	O	871	872	(	(	O	(	O	13	DEP	O
T23	B-Entity	872	875	NAC	NAC	B-NP	NN	O	13	DEP	O
O	O	875	876	)	)	O	)	O	10	NMOD	O
O	O	876	877	,	,	O	,	O	17	P	O
O	O	878	879	a	a	B-NP	DT	O	17	NMOD	O
O	O	880	886	potent	potent	I-NP	JJ	O	17	NMOD	O
O	O	887	898	antioxidant	antioxidant	I-NP	NN	O	19	SUB	O
O	O	898	899	,	,	O	,	O	17	P	O
O	O	900	909	decreased	decrease	B-VP	VBD	O	0	ROOT	O
T24	B-Entity	910	912	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T24	I-Entity	912	913	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T24	I-Entity	913	918	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T24	I-Entity	919	920	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	921	931	activation	activation	I-NP	NN	O	19	OBJ	O
O	O	932	938	caused	cause	B-VP	VBN	O	24	NMOD	O
O	O	939	941	by	by	B-PP	IN	O	25	VMOD	O
T6	B-Protein	942	944	IL	IL	B-NP	NN	B-protein	38	NMOD	B-protein
T6	I-Protein	944	945	-	-	O	HYPH	I-protein	27	NMOD	I-protein
T6	I-Protein	945	946	4	4	B-NP	CD	I-protein	27	NMOD	I-protein
O	O	946	947	,	,	O	,	O	38	P	O
O	O	948	952	anti	anti	B-NP	AFX	O	34	NMOD	O
O	O	952	953	-	-	I-NP	HYPH	B-protein	34	NMOD	B-protein
T7	B-Protein	953	957	CD40	CD40	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	958	961	mAb	mAb	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	961	962	,	,	O	,	O	38	P	O
O	O	963	965	or	or	O	CC	O	38	NMOD	O
O	O	966	971	their	their	B-NP	PRP$	O	38	NMOD	O
O	O	972	983	combination	combination	I-NP	NN	O	26	PMOD	O
O	O	983	984	.	.	O	.	O	19	P	O

T25	B-Entity	985	988	NAC	NAC	B-NP	NN	O	2	SUB	O
O	O	989	992	was	be	B-VP	VBD	O	15	VMOD	O
O	O	993	997	also	also	B-ADVP	RB	O	2	VMOD	O
O	O	998	1007	effective	effective	B-ADJP	JJ	O	2	PRD	O
O	O	1008	1010	in	in	B-PP	IN	O	4	AMOD	O
O	O	1011	1022	diminishing	diminish	B-VP	VBG	O	5	PMOD	O
T26	B-Entity	1023	1031	germline	germline	B-NP	NN	B-DNA	10	NMOD	B-DNA
T26	I-Entity	1032	1033	C	C	I-NP	NN	O	10	NMOD	O
T26	I-Entity	1034	1041	epsilon	epsilon	I-NP	NN	O	10	NMOD	O
O	O	1042	1055	transcription	transcription	I-NP	NN	O	6	OBJ	O
O	O	1055	1056	,	,	O	,	O	15	P	O
O	O	1057	1060	and	and	O	CC	O	15	VMOD	O
O	O	1061	1064	its	its	B-NP	PRP$	O	14	NMOD	O
O	O	1065	1072	potency	potency	I-NP	NN	O	15	SUB	O
O	O	1073	1076	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1077	1083	higher	high	B-ADJP	JJR	O	15	PRD	O
O	O	1084	1086	in	in	B-PP	IN	O	16	AMOD	O
O	O	1087	1095	cultures	culture	B-NP	NNS	O	17	PMOD	O
O	O	1096	1108	costimulated	costimulate	B-VP	VBN	O	18	NMOD	O
O	O	1109	1113	with	with	B-PP	IN	O	19	VMOD	O
T8	B-Protein	1114	1116	IL	IL	B-NP	NN	B-protein	22	NMOD	B-protein
T8	I-Protein	1116	1117	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T8	I-Protein	1117	1118	4	4	I-NP	CD	I-protein	22	NMOD	I-protein
O	O	1119	1122	and	and	O	CC	O	28	NMOD	O
O	O	1123	1127	anti	anti	B-NP	AFX	O	28	NMOD	O
O	O	1127	1128	-	-	I-NP	HYPH	B-protein	28	NMOD	B-protein
T9	B-Protein	1128	1132	CD40	CD40	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1133	1136	mAb	mAb	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	1137	1141	than	than	B-PP	IN	O	16	AMOD	O
O	O	1142	1144	in	in	B-PP	IN	O	29	PMOD	O
O	O	1145	1150	those	those	B-NP	DT	O	30	PMOD	O
O	O	1151	1161	stimulated	stimulate	B-VP	VBN	O	31	NMOD	O
O	O	1162	1166	with	with	B-PP	IN	O	32	VMOD	O
T10	B-Protein	1167	1169	IL	IL	B-NP	NN	B-protein	36	NMOD	B-protein
T10	I-Protein	1169	1170	-	-	I-NP	HYPH	I-protein	36	P	I-protein
T10	I-Protein	1170	1171	4	4	I-NP	CD	I-protein	33	PMOD	I-protein
O	O	1172	1177	alone	alone	I-NP	RB	O	36	NMOD	O
O	O	1177	1178	.	.	O	.	O	15	P	O

O	O	1179	1184	These	These	B-NP	DT	O	2	NMOD	O
O	O	1185	1192	results	result	I-NP	NNS	O	3	SUB	O
O	O	1193	1201	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1202	1206	that	that	B-SBAR	IN	O	3	VMOD	O
T11	B-Protein	1207	1209	IL	IL	B-NP	NN	B-protein	9	NMOD	B-protein
T11	I-Protein	1209	1210	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T11	I-Protein	1210	1211	4	4	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	1212	1215	and	and	O	CC	O	9	NMOD	O
O	O	1216	1224	ligation	ligation	B-NP	NN	O	12	SUB	O
O	O	1225	1227	of	of	B-PP	IN	O	9	NMOD	O
T12	B-Protein	1228	1232	CD40	CD40	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	1233	1239	induce	induce	B-VP	VBP	O	4	SBAR	O
O	O	1240	1242	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	1242	1243	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
O	O	1243	1248	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	1249	1250	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	1251	1261	expression	expression	I-NP	NN	O	12	OBJ	O
O	O	1262	1265	via	via	B-PP	IN	O	12	VMOD	O
O	O	1266	1268	at	at	B-ADVP	IN	O	18	PMOD	O
O	O	1269	1274	least	least	I-ADVP	JJS	O	19	AMOD	O
O	O	1275	1276	a	a	B-NP	DT	O	22	NMOD	O
O	O	1277	1286	mechanism	mechanism	I-NP	NN	O	18	PMOD	O
O	O	1287	1296	dependent	dependent	B-ADJP	JJ	O	22	NMOD	O
O	O	1297	1299	on	on	B-PP	IN	O	23	AMOD	O
O	O	1300	1303	the	the	B-NP	DT	O	29	NMOD	O
O	O	1304	1307	PI3	PI3	I-NP	NN	B-protein	29	NMOD	B-protein
O	O	1307	1308	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
O	O	1308	1314	kinase	kinase	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	1315	1322	pathway	pathway	I-NP	NN	O	24	PMOD	O
O	O	1323	1326	and	and	O	CC	O	3	VMOD	O
O	O	1327	1334	suggest	suggest	B-VP	VBP	O	3	VMOD	O
O	O	1335	1339	that	that	B-SBAR	IN	O	31	VMOD	O
T27	B-Entity	1340	1342	NF	NF	B-NP	NN	B-protein	36	NMOD	B-protein
T27	I-Entity	1342	1343	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
T27	I-Entity	1343	1348	kappa	kappa	I-NP	NN	I-protein	36	NMOD	I-protein
T27	I-Entity	1349	1350	B	B	I-NP	NN	I-protein	40	SUB	I-protein
O	O	1351	1360	sensitive	sensitive	B-ADJP	JJ	O	36	NMOD	O
O	O	1361	1363	to	to	B-PP	TO	O	37	AMOD	O
T28	B-Entity	1364	1367	NAC	NAC	B-NP	NN	O	38	PMOD	O
O	O	1368	1371	may	may	B-VP	MD	O	32	SBAR	O
O	O	1372	1376	play	play	I-VP	VB	O	40	VC	O
O	O	1377	1378	a	a	B-NP	DT	O	43	NMOD	O
O	O	1379	1383	role	role	I-NP	NN	O	41	OBJ	O
O	O	1384	1386	in	in	B-PP	IN	O	41	VMOD	O
O	O	1387	1397	regulating	regulate	B-VP	VBG	O	44	PMOD	O
T29	B-Entity	1398	1406	germline	germline	B-NP	NN	B-DNA	49	NMOD	B-DNA
T29	I-Entity	1407	1408	C	C	I-NP	NN	O	49	NMOD	O
T29	I-Entity	1409	1416	epsilon	epsilon	I-NP	NN	O	49	NMOD	O
O	O	1417	1430	transcription	transcription	I-NP	NN	O	45	OBJ	O
O	O	1430	1431	.	.	O	.	O	3	P	O
